FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023102754> ?p ?o ?g. }

• W2023102754 endingPage "2756" @default.
• W2023102754 startingPage "2750" @default.
• W2023102754 abstract "Abstract Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). Methods Subjects included 457 patients with early RA (duration of ≤3 years) who participated in a randomized controlled trial comparing weekly methotrexate and 2 dosages of etanercept (10 mg twice weekly and 25 mg twice weekly). Our primary outcome measure was achievement of 50% improvement in disease activity according to the criteria of the American College of Rheumatology (ACR50 response) after 12 months of treatment. Subjects were genotyped for HLA–DRB1 alleles and polymorphisms in the following genes: TNF , LTA , TNFRSF1A, TNFRSF1B , FCGR2A , FCGR3A , and FCGR3B . Univariate and multivariate analyses were performed to define the impact of specific polymorphisms and haplotypes on response to treatment. Covariates for the multivariate analyses included sex, ethnicity, age, disease duration, and baseline values for rheumatoid factor and the tender and swollen joint counts. Results The presence of 2 HLA–DRB1 alleles encoding the shared epitope (SE) (compared with 1 or 0 copies) was associated with response to treatment with standard‐dose etanercept (odds ratio [OR] 4.3, 95% confidence interval [95% CI] 1.8–10.3). Among Caucasian patients, 2 extended haplotypes that included the HLA–DRB1 alleles *0404 and *0101 (both of which encode the SE) and 6 single‐nucleotide polymorphisms in the LTA – TNF region were associated with response to treatment. In a multivariate model that included treatment received and the aforementioned covariates, the ORs for the association of these haplotypes with achievement of an ACR50 response at 12 months were 2.5 (95% CI 0.8–7.3) and 4.9 (95% CI 1.5–16.1) for the *0404‐ and *0101‐containing haplotypes, respectively. Conclusion Genetic variation in the HLA–DRB1 and the LTA – TNF regions is significantly associated with response to treatment of early RA. These findings may have clinical application through the identification of patients who are most likely to benefit from treatment with methotrexate or etanercept." @default.
• W2023102754 created "2016-06-24" @default.
• W2023102754 creator A5007210976 @default.
• W2023102754 creator A5007576322 @default.
• W2023102754 creator A5011480199 @default.
• W2023102754 creator A5052354656 @default.
• W2023102754 creator A5053778312 @default.
• W2023102754 creator A5058419289 @default.
• W2023102754 creator A5066780563 @default.
• W2023102754 creator A5068296122 @default.
• W2023102754 creator A5075129503 @default.
• W2023102754 creator A5077895438 @default.
• W2023102754 creator A5082388906 @default.
• W2023102754 creator A5090731148 @default.
• W2023102754 date "2004-09-01" @default.
• W2023102754 modified "2023-10-14" @default.
• W2023102754 title "The influence of genetic variation in the HLA-DRB1 andLTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept" @default.
• W2023102754 cites W1646511677 @default.
• W2023102754 cites W1974003531 @default.
• W2023102754 cites W2003370133 @default.
• W2023102754 cites W2013484552 @default.
• W2023102754 cites W2015865604 @default.
• W2023102754 cites W2029993165 @default.
• W2023102754 cites W2034464736 @default.
• W2023102754 cites W2040967116 @default.
• W2023102754 cites W2044360617 @default.
• W2023102754 cites W2048462515 @default.
• W2023102754 cites W2050390987 @default.
• W2023102754 cites W2053382138 @default.
• W2023102754 cites W2057827220 @default.
• W2023102754 cites W2065843132 @default.
• W2023102754 cites W2084457591 @default.
• W2023102754 cites W2091852263 @default.
• W2023102754 cites W2098919737 @default.
• W2023102754 cites W2106931069 @default.
• W2023102754 cites W2110177517 @default.
• W2023102754 cites W2110755408 @default.
• W2023102754 cites W2122833930 @default.
• W2023102754 cites W2131424931 @default.
• W2023102754 cites W2140738389 @default.
• W2023102754 cites W2159106700 @default.
• W2023102754 cites W2171896579 @default.
• W2023102754 cites W2340084730 @default.
• W2023102754 doi "https://doi.org/10.1002/art.20469" @default.
• W2023102754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15457442" @default.
• W2023102754 hasPublicationYear "2004" @default.
• W2023102754 type Work @default.
• W2023102754 sameAs 2023102754 @default.
• W2023102754 citedByCount "160" @default.
• W2023102754 countsByYear W20231027542012 @default.
• W2023102754 countsByYear W20231027542013 @default.
• W2023102754 countsByYear W20231027542014 @default.
• W2023102754 countsByYear W20231027542015 @default.
• W2023102754 countsByYear W20231027542016 @default.
• W2023102754 countsByYear W20231027542017 @default.
• W2023102754 countsByYear W20231027542018 @default.
• W2023102754 countsByYear W20231027542019 @default.
• W2023102754 countsByYear W20231027542020 @default.
• W2023102754 countsByYear W20231027542021 @default.
• W2023102754 countsByYear W20231027542022 @default.
• W2023102754 countsByYear W20231027542023 @default.
• W2023102754 crossrefType "journal-article" @default.
• W2023102754 hasAuthorship W2023102754A5007210976 @default.
• W2023102754 hasAuthorship W2023102754A5007576322 @default.
• W2023102754 hasAuthorship W2023102754A5011480199 @default.
• W2023102754 hasAuthorship W2023102754A5052354656 @default.
• W2023102754 hasAuthorship W2023102754A5053778312 @default.
• W2023102754 hasAuthorship W2023102754A5058419289 @default.
• W2023102754 hasAuthorship W2023102754A5066780563 @default.
• W2023102754 hasAuthorship W2023102754A5068296122 @default.
• W2023102754 hasAuthorship W2023102754A5075129503 @default.
• W2023102754 hasAuthorship W2023102754A5077895438 @default.
• W2023102754 hasAuthorship W2023102754A5082388906 @default.
• W2023102754 hasAuthorship W2023102754A5090731148 @default.
• W2023102754 hasBestOaLocation W20231027541 @default.
• W2023102754 hasConcept C104317684 @default.
• W2023102754 hasConcept C126322002 @default.
• W2023102754 hasConcept C156957248 @default.
• W2023102754 hasConcept C180754005 @default.
• W2023102754 hasConcept C197754878 @default.
• W2023102754 hasConcept C198451711 @default.
• W2023102754 hasConcept C203014093 @default.
• W2023102754 hasConcept C2776232647 @default.
• W2023102754 hasConcept C2777226972 @default.
• W2023102754 hasConcept C2777575956 @default.
• W2023102754 hasConcept C2781059491 @default.
• W2023102754 hasConcept C44249647 @default.
• W2023102754 hasConcept C54355233 @default.
• W2023102754 hasConcept C71924100 @default.
• W2023102754 hasConcept C86803240 @default.
• W2023102754 hasConceptScore W2023102754C104317684 @default.
• W2023102754 hasConceptScore W2023102754C126322002 @default.
• W2023102754 hasConceptScore W2023102754C156957248 @default.
• W2023102754 hasConceptScore W2023102754C180754005 @default.
• W2023102754 hasConceptScore W2023102754C197754878 @default.
• W2023102754 hasConceptScore W2023102754C198451711 @default.
• W2023102754 hasConceptScore W2023102754C203014093 @default.
• W2023102754 hasConceptScore W2023102754C2776232647 @default.

• next